Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Ribbons, Karen Ann ^a   McElduff, Patrick ^b   Boz, Cavit ^c   Trojano, Maria ^d   Izquierdo, Guillermo ^e   Duquette, Pierre ^f   Girard, Marc ^f   Grand'Maison, Francois ^g   Hupperts, Raymond ^h   Grammond, Pierre ⁱ   Oreja Guevara, Celia ^j   Petersen, Thor ^k   Bergamaschi, Roberto ^l   Giuliani, Giorgio ^m   Barnett, Michael ⁿ   Van Pesch, Vincent ^o   Amato, Maria Pia ^p   Iuliano, Gerardo ^q   Fiol, Marcela ^r   Slee, Mark ^s   Verheul, Freek ^t   Cristiano, Edgardo ^u   Fernandez Bolanos, Ricardo ^e   Saladino, Maria Laura ^v   Rio, Maria Edite ^w   Cabrera Gomez, Jose ^x   Butzkueven, Helmut ^y   Van Munster, Erik ^z   Braber Moerland, Leontien Den ^aa   Spitaleri, Daniele La ^ab   Lugaresi, Alessandra ^ac   Shaygannejad, Vahid ^ad   Gray, Orla ^v   Deri, Norma ^ae   Alroughani, Raed ^af   Lechner Scott, Jeannette ^a   more..

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^d UNIVERSITY OF BARI   (Italy)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f NOTRE DAME HOSPITAL   (Canada)

^g Neuro Rive Sud   (Canada)

^h Zuyderland Medical Centre   (Netherlands)

ⁱ Hotel Dieu de Levis Hospital   (Canada)

^j HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^k AARHUS UNIVERSITY HOSPITAL   (Denmark)

^l C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^m Ospedale di Macerata   (Italy)

ⁿ UNIVERSITY OF SYDNEY   (Australia)

^o CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^p UNIVERSITY OF FLORENCE   (Italy)

^q Ospedali Riuniti di Salerno   (Italy)

^r FLENI   (Argentina)

^s FLINDERS MEDICAL CENTRE   (Australia)

^t Groen Hart Ziekenhuis   (Netherlands)

^u HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^v CRAIGAVON AREA HOSPITAL   (United Kingdom)

^w HOSPITAL DE SÃO JOÃO   (Portugal)

^x CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^y ROYAL MELBOURNE HOSPITAL   (Australia)

^z JEROEN BOSCH HOSPITAL   (Netherlands)

^aa Francicus Ziekenhuis   (Netherlands)

^ab AORN San Giuseppe Moscati   (Italy)

^ac UNIVERSITY OF CHIETI   (Italy)

^ad ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ae HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^af AL AMIRI HOSPITAL   (Kuwait)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DATA MINING; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE REGISTRY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PROSPECTIVE STUDY; RELAPSE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; AGED; FACTUAL DATABASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; REGISTER; SEVERITY OF ILLNESS INDEX;

IMMUNOLOGIC FACTOR;

ADULT; AGED; COHORT STUDIES; DATABASES, FACTUAL; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84934938814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122686     Document Type: Article

References (37)

1. Bove R, Chitnis T (2013) Sexual disparities in the incidence and course of MS. Clinical Immunology 149: 201-210. doi: 10.1016/j.clim.2013.03.005 PMID: 23608496
2. Ramopagopalan SV, Byrnes JK, Orton SM, Dyment DA, Guimond C, Yee IM, et al. (2010) Sex ratio of multiple sclerosis and clinical phenotype. European Journal of Neurology 17: 634-637. doi: 10.1111/j.1468-1331.2009.02850.x PMID: 19968710
3. Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T (2012) Effect of gender on late-onset multiple sclerosis. Multiple Sclerosis Journal 18(10): 1472-1479. PMID: 22383227
4. Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F for the LORSEP Group (2008) Natural history of multiple sclerosis in a population-based group. European Journal of Neurology 15: 916-921. doi: 10.1111/j.1468-1331.2008.02241.x PMID: 18637953
5. Debouverie M (2009) Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France. Journal of Neurological Sciences 286: 14-17.
6. Shirani A, Zhao Y, Kingwell E, Rieckmann, Tremlett H (2012) Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009). Multiple Sclerosis Journal 18(4): 442-450. doi: 10.1177/1352458511422097 PMID: 21952097
7. Confavreaux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. The New England Journal of Medicine 343:1430-14338. PMID: 11078767
8. Confavreaux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126: 770-782. PMID: 12615637
9. Vukusic S, Confavreaux C (2003) Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. Journal of Neurological Sciences 206: 135-137.
10. Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J et al. (2010) Evidence of a two-stage disability progression in multiple sclerosis. Brain 133: 1900-1913. doi: 10.1093/brain/awq076 PMID: 20423930
11. Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, et al. (2013) No sex-specific difference in disease trajectory in multiple sclerosis patients befoe and after age 50. Biomed Central Neurology 13: 73-80 doi: 10.1186/1471-2377-13-73 PMID: 23822612
12. Gholipour T, Healy B, Baruch NF, Weiner HL Chitnis T (2011) Demographic and clinical characteristics of malignant multiple sclerosis. Neurology 76: 1996-2001. doi: 10.1212/WNL.0b013e31821e559d PMID: 21646626
13. Cossburn M, Ingram G, Hirst C, Ben-Shlomo Y, Pickersgill TP, Robertson NP (2012) Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multiple Sclerosis Journal 18(1): 45-54. doi: 10.1177/1352458511417479 PMID: 21865412
14. Koch M, Kingwell E, Riekmann P, Tremlett H (2010) The natural history of secondary progressive multiple sclerosis. Journal of Neurology and Neuropsychiatry 81: 1039-1043.
15. Koch M, Mostert J, Heersema D, De Kayser J (2007) Progression in multiple sclerosis: Further evidence of an age dependent process. Journal of Neurological Sciences 255: 35-41.
16. Koch M, Uyttenboogaart M, Van Harten A, De Keyser J (2008) Factors associated with the risk of secondary progression in multiple sclerosis. Multiple Sclerosis 14: 799-803. doi: 10.1177/1352458508089361 PMID: 18573840
17. Miller DH,Leary SM (2007) Primary Progressive Multiple Sclerosis. Lancet Neurology 6: 903-912. PMID: 17884680
18. Katz Sand IB, Lublin FD (2013) Diagnosis and Differential Diagnosis of Multiple Sclerosis. Continuum Journal 19(4): 922-943.
19. Tremlett H, Zhao Y, Devonshire V (2009) Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. Journal of Neurology 256: 374-381. doi: 10.1007/s00415-009-0039-7 PMID: 19308306
20. Ebers G (2004) Natural history of primary progressive multiple sclerosis. Multiple Sclerosis 10: S8-S15. PMID: 15218804
21. Koch M, Kingwell E, Rieckmann P, Tremlett H (2009) The natural history of primary progressive multiple sclerosis. Neurology 73: 1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f PMID: 19996074
22. Tremlett H, Paty D, Devonshire V (2005) The natural history of primary progressive multiple sclerosis in British Columbia, Canada. Neurology 65: 1919-1923. PMID: 16380613
23. Harding K, Wardle M, Moore P, Tomassini V, Pickersgill T, Ben-Shlomo Y, et al. (2014) Modelling the natural history of primary progressive multiple sclerosis. Journal of Neurol Neurosurg Psychiatry (2014) May 14. pii: jnnp-2014-307791
24. Cottrell DA, Kremenchutzy M, Rice GPA, Hader W, Baskervelle J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122: 625-639. PMID: 10219776
25. Khaleeli Z, Ciccarelli O, Manfredonia F, Barkhof F, Brochet B, Cercignani M, et al. (2008) Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study. Annals of Neurology 63: 790-793. doi: 10.1002/ana.21375 PMID: 18383506
26. Butzkueven H, Chapman J, Cristiano E, Grand Maison F, Hoffmann M, Izquiderdo G, et al. (2006) MSBASE an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Multiple Sclerosis 12: 769-774. PMID: 17263005
27. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA). Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4): 907-911. PMID: 8780061
28. Rice GPA (2002) The natural history of secondary progressive multiple sclerosis: observations from the London study group. Multiple Sclerosis 8: 81-82. PMID: 11936492
29. Tremlett H, Paty D, Devonshire V (2006) Disability progression in multiple sclerosis is slower than previously reported. Neurology 66: 172-177. PMID: 16434648
30. Confavreaux C, Vukusic S (2006) Age a disability milestones in multiple sclerosis. Brain 129: 595-605. PMID: 16415309
31. Tremlett H, Zhao Y, Devonshire V (2008) Natural history of secondary progressive multiple sclerosis. Multiple Sclerosis 14: 314-324. doi: 10.1177/1352458507084264 PMID: 18208898
32. Spelman T, Trojano M, Duquette P, Izquierdo G, Lugaresi A, Grammond P, et al. (2013) Defining secondary progressive multiple sclerosis: Is it possible to diagnose early? Multiple Sclerosis 19 (11): 38
33. Stankoff B, Mrejen S, Tourbah A, Fontaine B, Lyon-Caen O, lubetzki C, et al. (2007) Age at onset determines the occurrence of the progressive phase of multiple sclerosis. Neurology 68(10): 779-781. PMID: 17339588
34. Kalincik T, Vivek V, Lechner-Scott J, Trojano M, Izquierdo G, Grand'Maison F, et al. (2013) Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain 136: 3609-3617. doi: 10.1093/brain/awt281 PMID: 24142147
35. Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y on behalf of the UBC Neurologists (2009) Impact of multiple sclerosis relapses on progression diminishes with time. Neurology 73: 1616-1623. doi: 10.1212/WNL.0b013e3181c1e44f PMID: 19890070
36. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. (2010) The natural history of multiple sclerosis, a geographical based study 10: relapses and long-term disability. Brain 133: 1914-1929. doi: 10.1093/brain/awq118 PMID: 20534650
37. Cottrell DA, Kremenchutzky M, Rice GPA, Hader W, Baskerville J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 (Pt 4): 641-647. PMID: 10219777